[(5-Fluoro-1H-benzimidazol-2-yl)methyl]amine dihydrochloride | 1216862-84-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并咪唑类
• 英文名称: [(5-Fluoro-1H-benzimidazol-2-yl)methyl]amine dihydrochloride
• 英文别名: (6-fluoro-1H-benzimidazol-2-yl)methanamine;dihydrochloride
• CAS: 1216862-84-8
• 化学式: C8H10Cl2FN3
• mdl: MFCD12914002
• 分子量: 238.09
• InChiKey: BNAYMHMLRWAORU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.125
• 拓扑面积：
  54.7
• 氢给体数：
  4
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT

文献信息

• TRIAZINE COMPOUNDS AND USES THEREOF
  申请人：Aduro BioTech, Inc.

  公开号：EP3810600A1

  公开（公告）日：2021-04-28
• Surface Treatment
  申请人：INTERPHASE MATERIALS INC.

  公开号：US20200231842A1

  公开（公告）日：2020-07-23

  A surface treatment includes a functional component and a linking component, wherein the linking component is capable of hydrogen bonding and/or covalently linking with the functional component and is capable of hydrogen bonding and/or covalently linking with the surface to form a treated surface. The surface treatment provides a beneficial property to the surface when the surface treatment is bonded to the surface.
• Triazine Compounds and Uses Thereof
  申请人：Aduro Biotech, Inc.

  公开号：US20210246122A1

  公开（公告）日：2021-08-12

  The present invention relates to triazine compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating autoimmune, inflammatory, and neurodegenerative diseases by administering these compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes.